AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $761,716 | -48.8% | 10,600 | -45.0% | 0.00% | -70.0% |
Q4 2022 | $1,487,297 | -99.7% | 19,283 | +46.8% | 0.01% | +100.0% |
Q2 2022 | $502,993,000 | -62.2% | 13,133 | -59.2% | 0.01% | -54.5% |
Q1 2022 | $1,331,847,000 | +42.0% | 32,178 | +182.3% | 0.01% | -26.7% |
Q2 2020 | $937,992,000 | – | 11,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,131 | $71,901,000 | 48.66% |
Fairmount Funds Management LLC | 220,098 | $15,682,000 | 6.64% |
WMS Partners, LLC | 250,000 | $17,813,000 | 3.46% |
RTW INVESTMENTS, LP | 1,670,938 | $119,054,000 | 2.87% |
MORGAN JESS S & CO INC | 39,018 | $2,780,000 | 2.77% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,722,823 | $122,751,000 | 2.68% |
RA Capital Management | 2,035,132 | $145,003,000 | 2.65% |
Nicholas Investment Partners, LP | 187,756 | $13,378,000 | 1.45% |
Cormorant Asset Management, LP | 250,000 | $17,813,000 | 0.68% |
Parkman Healthcare Partners LLC | 35,010 | $2,494,000 | 0.66% |